Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to monitor and quality assure the efficacy and safety of
Monofer® in a broad patient population when Monofer® is used according to the Monofer® label
(SPC) in current practice and where standard routines are being followed.